AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Global Pharma Giants Advocate for Weight-Loss Drugs on PBS: A Push for Subsidised Solutions
January 06, 2025 11:35 AM AEDT| By Team Kalkine MediaHighlights,Mounjaro's,PBS Listing Push,: Eli Lilly aims to secure government subsidies for,Mounjaro,on the Pharmaceutical Benefits Scheme (PBS), targeting obesity-related health risks.,Economic and Healthcare Implications,: Advocates highlight potent...
Percheron Therapeutics Redirects Focus After Trial Results
January 06, 2025 11:24 AM AEDT| By Team Kalkine MediaHighlights,Percheron Therapeutics focuses on rebuilding after clinical trial outcomes.,The company explores diversification and pipeline expansion strategies.,Strategic review underway for future opportunities beyond Duchenne muscular dystrophy.,Perc...
Imugene Doses First Australian Patient in Phase 1b Azer-Cel Clinical Trial
January 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights:,Imugene (ASX:IMU) has commenced its Phase 1b clinical trial for azer-cel at Royal Prince Alfred Hospital in Sydney, marking a significant milestone in cancer treatment.,The trial will focus on patients with relapsed or refractory diffuse...
LTR Pharma secures national distribution agreement for its ED treatment with a major pharmacy.
January 02, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Symbion to distribute Spontan, an innovative nasal spray for erectile dysfunction, across its extensive pharmacy network.,Collaboration supports LTR Pharma’s early access program and establishes a scalable distribution framework.,Spontan’...
Labor Plans Major Health Policy Overhaul Ahead of Federal Election
January 02, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights:,Labor intends to expand bulk billing, increase urgent care clinics, and reform GP subsidies under Medicare to alleviate healthcare costs.,Prime Minister Albanese's government will lift bulk billing incentives and implement changes to GP p...
The Expanding Potential of GLP-1 Drugs: A Transformative Medical Revolution
January 02, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlight:,GLP-1 receptor agonists, like Ozempic and Wegovy, initially developed for diabetes and obesity, are now showing promise in treating a range of conditions including cardiovascular disease, chronic kidney disease, Alzheimer’s, and addiction....
Proteomics International’s OxiDx Test Demonstrates Breakthrough in Muscle Damage Recovery for Marathon Runners
December 31, 2024 12:36 PM AEDT| By Team Kalkine MediaHighlights,OxiDx test shows potential to identify muscle damage and assess recovery in elite marathon runners.,Study highlights the need for personalized recovery monitoring in high-performance sports.,The OxiDx test is set for Australian launch in H...
Advances in Biopharma: Kidney Imaging, Therapies, and Diagnostics
December 30, 2024 06:13 PM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (TLX) is advancing its kidney cancer imaging agent for potential US approval.,Dimerix (DXB) achieves a milestone in recruiting for its phase III kidney disease trial.,Proteomics International (PIQ) develops a highly a...
Imricor Medical Expands into Middle East with First Sales in Qatar, Shares Rise 8.55%
December 30, 2024 01:38 PM AEDT| By Team Kalkine MediaHighlights:,Imricor has secured its first purchase order for MRI-guided ablation equipment in Qatar.,The company is working with exclusive distributor East Agency WWL to introduce its iCMR labs to leading cardiac centres in Qatar.,Imricor’s share pri...
Proteomics International Shares Surge Nearly 20% on Monday. Here's Why.
December 30, 2024 01:23 PM AEDT| By Team Kalkine MediaHighlights,Proteomics International Laboratories unveils PromarkerEndo blood test, capable of diagnosing all stages of endometriosis with high accuracy.,The test’s breakthrough results, published in,Human Reproduction,, could revolutionize diagnosis,...
Goodman Group Surges Over 45% in 2024, Fueled by AI-Driven Data Centre Demand
December 30, 2024 11:43 AM AEDT| By Team Kalkine MediaHighlights,Goodman Group's stock rises over 45% in 2024, its best performance since 2006.,Data centres now make up 42% of Goodman’s AU$12.8 billion development pipeline.,Australia's data-centre market sees booming investment, led by global hyperscale...
Pro Medicus Scores Fourth Major Contract in a Month, Shares Edge Higher
December 30, 2024 11:37 AM AEDT| By Team Kalkine MediaHighlights,Pro Medicus secures a $15 million, five-year contract with Duke University Health System.,This marks the company’s fourth significant deal in just over a month, building on prior multi-million dollar agreements.,The deal expands Pro Medicu...
Pro Medicus (ASX:PME) Expands North American Reach with Duke University Deal
December 30, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights,- Pro Medicus (PME) secures a $15 million deal with Duke University Health System.,- The agreement extends Pro Medicus’ cloud-based imaging services through Visage 7 Open Archive.,- The Visage 7 Viewer contract has been extended to 2029.,P...
ASX Small Caps to Watch: Undervalued Stocks With Insider Confidence in December 2024
December 27, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights:,Resilient Market Amid Challenges,: The ASX 200 showed a modest gain of 0.29% in December 2024, despite lingering inflation concerns. Small-cap stocks have gained attention for their growth potential, especially those exhibiting insider ac...
AVITA Medical Secures FDA Approval for RECELL GO® Mini, Expanding Treatment Options for Smaller Wounds
December 24, 2024 11:25 AM AEDT| By Team Kalkine MediaHighlights:,FDA Approval:,RECELL GO Mini, designed for smaller wounds, enhances the functionality of the RECELL GO platform.,Optimized Design:,The cartridge minimizes resource use and waste, broadening accessibility for clinicians.,Market Growth:,Tar...
Imugene Secures Major Capital Boost to Advance Clinical Trials
December 24, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights,- Imugene extends cash runway to late 2025 through strategic capital injection.,- Funding supports clinical trials for key programs, including azer-cel and VAXINIA.,- Additional cost-saving measures strengthen financial position.,Imugene (...
Avita Medical's Spray-On Skin Device Earns FDA Approval
December 24, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights,- Avita Medical (AVH) receives FDA approval for RECELL GO Mini, expanding its advanced wound care solutions.,- The new Mini GO device targets smaller wounds, enhancing resource efficiency and flexibility for clinicians.,- Avita plans to in...
Polynovo's Record Sales Drive ASX Momentum Amid Market Recovery
December 23, 2024 02:55 PM AEDT| By Team Kalkine MediaHighlights:,Polynovo,(PNV) surged on record-breaking monthly sales.,ASX recovered from last week’s technical disruptions to open on time.,Real Estate, Financials, and Consumer Discretionary sectors lead ASX gains.,The Australian Securities Exchange (...
PolyNovo Achieves Record $10.1M Monthly Sales in November 2024
December 23, 2024 01:12 PM AEDT| By Team Kalkine MediaHighlights,Record Monthly Sales:,PolyNovo reported,$10.1M,in unaudited sales for November 2024, marking the company's highest monthly performance to date.,Geographic Expansion:,United States:,November sales reached,$7.0M,, contributing to year-to-dat...
Rhythm Biosciences Acquires Genetype Business from Genetic Technologies
December 23, 2024 12:34 PM AEDT| By Team Kalkine MediaHighlights,Strategic Acquisition:,Rhythm Biosciences has entered into an Asset Sale Agreement (ASA) with the administrators of Genetic Technologies Ltd (GTG) to acquire the Genetype business, a leader in genetic risk assessment for cancers.,Transacti...
Advertise your brand on Kalkine Media